Sentences with phrase «desire disorder»

She has professional training in relationship, couples and sex therapy and has focused studies on sexuality, sexual dysfunction and sexual desire disorders.

She has had extensive training in relationship, couples and sex therapy and focused her studies on sexuality, sexual dysfunction and sexual desire disorders.

Late last year, the U.S. Food and Drug Administration rejected Sprout Pharmaceuticals» treatment for hyposexual desire disorder (HSDD) in women — in simple terms, a lack of sexual desire — because it wasn't convinced of the benefits.

You don't have to live with desire disorders, inability to become physically aroused or have an orgasm (climax) as well as pain disorders.

But what about the emotional / psychological toll having something like erectile dysfunction or a sexual desire disorder takes on you as a person and the people you're intending to have sex with?

The FDA has twice rejected flibanserin, sometimes touted as a «female Viagra,» first when Boehringer Ingelheim pitched it in 2010 and then again in 2013 after tiny Sprout landed rights to the drug and then mounted its own campaign for an approval for hypoactive sexual desire disorder in premenopausal women.

This work opens up new and exciting possibilities for the treatment of patients with psychosexual disorders such as hyposexual desire disorder.

But while the U.S. Food and Drug Administration has approved more than two dozen drugs targeting a range of male sexual matters, pharma has turned a cold shoulder to female dysfunction, despite the prevalence of conditions like hypoactive sexual desire disorder, a chronic disinterest in sex estimated to affect 8 to 14 percent of American women ages 20 to 49.

The drug, flibanserin or «Addyi», treats a condition called hypoactive sexual desire disorder (HSDD), which can cause chronic low desires to have sex in women.

The drug treats a condition called hypoactive sexual desire disorder (HSDD), which can cause chronic low desires to have sex in women.

Here's a quick summary of what happened: Sprout is a Raleigh, N.C. - based developer of a drug intended to treat hypoactive sexual desire disorder — a persistent lack of libido — in pre-menopausal women.

Many women — some studies estimate this number is as high as one - third of all adult women — have a condition known as female hypoactive sexual desire disorder (HSDD).

The company said it would instead focus on educating doctors about the drug and the condition it treats, hypoactive sexual desire disorder.

Flibanserin, marketed by Valeant as Addyi, was approved by the U.S. Food and Drug Administration (FDA) in 2015 to treat premenopausal women with hypoactive sexual desire disorder (HSDD).

In August, the FDA approved Addyi, the first drug authorized to treat hypoactive sexual desire disorder (HSDD), or lack of libido.

The scientists, led by Professor Andrea Fagiolini, took recruited 38 men who had been attending the Urology Department of the University of Siena following a diagnosis of hypoactive sexual desire disorder or sexual arousal disorder — both conditions which are characterised by a lack of interest in sex.

The other seven suffered from hypoactive sexual desire disorder.

Perhaps men with hypoactive sexual desire disorder couldn't feel desire because their brains were keeping their emotions bottled up.

The drug was approved to treat hypoactive sexual desire disorder, or HSDD.

Hypoactive sexual desire disorder (HSDD), on the other hand, is a deficiency or absence of sexual fantasies and desire causing marked distress or interpersonal difficulty.

The drug is intended to treat hypoactive sexual desire disorder (HSDD)-- a persistent lack of libido — in premenopausal women.

Your interest in sex may diminish (low libido or hypoactive sexual desire disorder, HSSD) and you may develop a dry vagina, so that intercourse is irritating (dyspareunia).

A low libido has been described as a hyposexual desire disorder.

Diagnoses include hypoactive sexual desire disorder, sexual aversion disorder, sexual arousal disorder, orgasmic disorder among others.

Dr. Ian Kerner will discuss the latest science - based research informing the treatment of common DSM - 5 sexual issues such as female sexual interest and arousal disorder (FSIAD), male hypoactive sexual desire disorder (HSDD), erectile disorder (ED), premature ejaculation (PE), female orgasmic disorder (FOD), and problematic sexual behaviors such as excessive use of internet pornography.

Men can have low libido and low sexual frequency for a number of reasons.Join sex therapist Laurie Watson and couple's therapist Adam Mathews as they discuss the various causes of male sexual desire disorder and what to do about it.

The diagnosis female sexual dysfunction disorder covers four conditions: lack of libido, known as hypoactive sexual desire disorder; lack of sensitivity or ability to be aroused, called female sexual arousal disorder; inability to have an orgasm, known as female orgasmic disorder; and pain during sex — which itself is divided into a number of categories.

What about when your sexual desire disorder or sexual aversion disorder is a symptom of past sexual trauma or guilt?

Tagged: plissit, intensive therapy, sex therapy, sex therapists, erectile dysfunction, sex addiction, clinical sexology, performance anxiety, sexual trauma, sexual aversion disorder, sexual desire disorder, gender identity, sexual identity, therapy, therapist, mental health, counselor, counseling, marriage and family, emotional affairs